CXCL5/CXCR2 axis in tumor microenvironment as potential diagnostic biomarker and therapeutic target-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CXCL5/CXCR2 axis in tumor microenvironment as potential diagnostic biomarker and therapeutic target

Published:2020-03 Issue:2-3 Volume:40 Page:69-80
ISSN:2523-3548
Container-title:Cancer Communications
language:en
Short-container-title:Cancer Communications

Author:

Zhang Wen¹,Wang Huishan¹,Sun Mingyang²,Deng Xueting¹,Wu Xueru¹,Ma Yilan¹,Li Mengjing³⁴,Shuoa Said Maisam¹,You Qiang¹³⁴,Miao Lin¹

Affiliation:

1. Medical Center for Digestive DiseasesThe Second Affiliated Hospital of Nanjing Medical University Nanjing 210011 Jiangsu P. R. China

2. Department of SurgeryThe Second Affiliated Hospital of Nanjing Medical University Nanjing 210011 Jiangsu P. R. China

3. Department of BiotherapyThe Second Affiliated Hospital of Nanjing Medical University Nanjing 210011 Jiangsu P. R. China

4. Key Laboratory for Aging and DiseaseNanjing Medical University Nanjing 210011 Jiangsu P. R. China

Funder

the Project of Jiangsu Provincial Key medical talents in Jiangsu Province

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cac2.12010

Reference97 articles.

1. Cancer and Microenvironment Plasticity: Double-Edged Swords in Metastasis

2. Microenvironmental regulation of therapeutic response in cancer

3. Interactions between cancer cells and bone microenvironment promote bone metastasis in prostate cancer;Zhang X.;Cancer Commun (Lond),2019

4. Paradoxical roles of the immune system during cancer development

5. Prognostic significance of CXCL5 expression in cancer patients: a meta‐analysis;Hu B;Cancer Cell International,2018

Cited by 143 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neutrophils as promising therapeutic targets in pancreatic cancer liver metastasis;International Immunopharmacology;2024-10

2. β-glucan combined with Envafolimab and Endostar as immune rechallenge for metastatic non-small cell lung cancer;BMC Immunology;2024-09-14

3. Characterization of pre- and on-treatment soluble immune mediators and the tumor microenvironment in NSCLC patients receiving PD-1/L1 inhibitor monotherapy;Cancer Immunology, Immunotherapy;2024-09-05

4. HCC-1 Accelerates Atherosclerosis by Inducing Endothelial Cell and Macrophage Pyroptosis and Serves as an Early Diagnostic Biomarker;Arteriosclerosis, Thrombosis, and Vascular Biology;2024-09

5. CXCL5 expression is associated with active signals of macrophages in the microenvironment of papillary thyroid carcinoma;Pathology - Research and Practice;2024-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3